Spread the loveThe annual NVIDIA GTC conference, held in San Jose from March 16 to 19, 2026, has once again positioned the company at the forefront of artificial intelligence (AI) technology. This ...
Morning Overview on MSN
Report: Nvidia is developing a $20B AI chip aimed at faster inference
Nvidia is reportedly developing a specialized processor aimed at accelerating AI inference, a move that could reshape how ...
Lightbits Labs Ltd. today is introducing a new architecture aimed at addressing one of the most stubborn bottlenecks in large-scale artificial intelligence inference: the growing mismatch between the ...
Nvidia's upcoming GTC conference will reveal CEO Jensen Huang's AI hardware, software, and partnership plans. Investors ...
0G’s Sealed Inference takes a fundamentally different approach: privacy by code. The architecture makes unauthorized data ...
Researchers present NorthPole – a brain-inspired chip architecture that blends computation with memory to process data efficiently at low-energy costs. Since its inception, computing has been ...
In addition to GPUs that handle the lion's share of AI training, Nvidia wants to introduce a chip for running AI workloads on a daily basis. Thanks to the ...
SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.
Training compute builds AI models. Inference compute runs them — repeatedly, at global scale, serving millions of users billions of times daily.
Inference protection is a preventive approach to LLM privacy that stops sensitive data from ever reaching AI models. Learn how de-identification enables secure, compliant AI workflows with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results